Free Trial

X4 Pharmaceuticals (XFOR) Short Interest Ratio & Short Volume

$1.01
+0.05 (+5.21%)
(As of 06/21/2024 ET)

X4 Pharmaceuticals Short Interest Data

Current Short Interest
11,880,000 shares
Previous Short Interest
12,210,000 shares
Change Vs. Previous Month
-2.70%
Dollar Volume Sold Short
$12.00 million
Short Interest Ratio
3.6 Days to Cover
Last Record Date
May 31, 2024
Outstanding Shares
167,940,000 shares
Percentage of Shares Shorted
7.07%
Today's Trading Volume
1,442,242 shares
Average Trading Volume
1,073,573 shares
Today's Volume Vs. Average
134%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling X4 Pharmaceuticals ?

Sign up to receive the latest short interest report for X4 Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

XFOR Short Interest Over Time

XFOR Days to Cover Over Time

XFOR Percentage of Float Shorted Over Time

X4 Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/202411,880,000 shares $12.00 million -2.7%N/A3.6 $1.01
5/15/202412,210,000 shares $11.92 million -7.4%N/A3.7 $0.98
4/30/202413,190,000 shares $14.77 million +7.6%N/A4.2 $1.12
4/15/202412,260,000 shares $15.33 million -0.6%N/A5.1 $1.25
3/31/202412,330,000 shares $17.14 million -13.3%N/A5.8 $1.39
3/15/202414,220,000 shares $13.19 million -1.3%N/A7.4 $0.93
2/29/202414,400,000 shares $13.98 million +8.8%N/A8.1 $0.97
2/15/202413,230,000 shares $12.52 million +3.4%N/A6.6 $0.95
1/31/202412,800,000 shares $10.00 million +6.8%N/A6.1 $0.78
1/15/202411,990,000 shares $9.83 million +3.2%N/A5.2 $0.82
12/31/202311,620,000 shares $9.74 million -1.0%N/A5.1 $0.84
12/15/202311,740,000 shares $8.38 million +2.8%N/A5.2 $0.71
11/30/202311,420,000 shares $8.91 million -0.3%N/A6.2 $0.78
11/15/202311,450,000 shares $9.00 million -0.5%N/A7.5 $0.79
10/31/202311,510,000 shares $9.21 million +5.8%N/A5.5 $0.80
10/15/202310,880,000 shares $9.70 million +2.5%N/A5.7 $0.89
9/30/202310,620,000 shares $11.58 million -2.4%N/A5.2 $1.09
9/15/202310,880,000 shares $12.08 million +5.7%N/A4.9 $1.11
8/31/202310,290,000 shares $13.17 million -6.8%N/A3.6 $1.28
8/15/202311,040,000 shares $13.25 million -8.4%N/A3.3 $1.20
7/31/202312,050,000 shares $21.57 million -11.2%N/A3.5 $1.79
7/15/202313,570,000 shares $25.51 million -5.7%N/A3.7 $1.88
6/30/202314,390,000 shares $27.92 million +57.4%N/A3.7 $1.94
6/15/20239,140,000 shares $20.75 million +7.0%N/A2.3 $2.27
5/31/20238,540,000 shares $17.34 million +189.5%N/A2.6 $2.03
5/15/20232,950,000 shares $4.48 million -2.6%N/A1.1 $1.52
4/30/20233,030,000 shares $4.45 million -14.2%N/A1.7 $1.47
4/15/20233,530,000 shares $4.06 million +86.8%N/A2.6 $1.15
3/31/20231,890,000 shares $1.64 million +10.5%N/A1.7 $0.87
3/15/20231,710,000 shares $1.55 million +34.7%N/A2.1 $0.91
2/28/20231,270,000 shares $1.19 million +22.1%N/A1.1 $0.94
2/15/20231,040,000 shares $1.04 million -3.7%N/A0.8 $1.00
1/31/20231,080,000 shares $1.11 million -13.6%N/A0.8 $1.03
1/15/20231,250,000 shares $1.51 million -20.9%N/A1 $1.21
12/30/20221,580,000 shares $1.57 million +17.9%N/A1.3 $0.99
12/15/20221,340,000 shares $1.08 million -12.4%N/A0.9 $0.81
11/30/20221,530,000 shares $2.30 million -0.7%N/A1.3 $1.50
11/15/20221,540,000 shares $2.93 million -4.9%N/A1.9 $1.90
10/31/20221,620,000 shares $3.08 million -1.8%N/A1.9 $1.90
10/15/20221,650,000 shares $3.33 million -8.8%N/A2.1 $2.02
Do you think trading w/emotion helps? (Ad)

Holding onto our losers too long and cutting our winners at the first sign of profit. Steven recognized that the only way to really solve this problem was to build an automated trading bot using a machine that has zero emotion.

Click here to join Steven LIVE this week.
9/30/20221,810,000 shares $3.10 million +272.0%N/A2.4 $1.71
9/15/2022486,600 shares $583,920.00 -11.3%N/A1.1 $1.20
8/31/2022548,700 shares $543,267.87 -57.5%N/A1.7 $0.99
8/15/20221,290,000 shares $1.88 million +92.2%N/A4.7 $1.46
7/31/2022671,200 shares $859,136.00 +13.8%4.3%3 $1.28
7/15/2022590,000 shares $631,300.00 -1.2%3.8%2.9 $1.07
6/30/2022597,000 shares $576,105.00 -9.4%2.7%2.9 $0.97
6/15/2022658,700 shares $744,331.00 +0.8%3.0%3.7 $1.13
5/31/2022653,300 shares $790,493.00 +6.3%2.9%2.7 $1.21
5/15/2022614,600 shares $737,520.00 -0.6%2.8%1.5 $1.20
4/30/2022618,000 shares $797,220.00 -15.9%2.9%1.5 $1.29
4/15/2022734,900 shares $1.04 million +15.7%3.4%1.8 $1.42
3/31/2022635,200 shares $1.11 million +12.9%3.0%1.6 $1.75
3/15/2022562,800 shares $1.11 million +22.1%2.9%1.2 $1.97
2/28/2022461,000 shares $691,500.00 +29.7%2.4%0.5 $1.50
2/15/2022355,500 shares $579,465.00 -34.5%1.8%0.4 $1.63
1/31/2022543,100 shares $1.12 million +26.0%2.6%0.6 $2.06
1/15/2022430,900 shares $900,581.00 -38.1%2.1%0.5 $2.09
12/31/2021695,800 shares $1.59 million +68.2%N/A0 $2.29
12/15/2021413,600 shares $835,472.00 +49.5%2.1%0.5 $2.02
11/30/2021276,600 shares $1.23 million +15.8%1.4%1.4 $4.45
11/15/2021238,800 shares $1.15 million -0.7%1.2%1.4 $4.83
10/29/2021240,400 shares $1.16 million -7.7%1.2%1.4 $4.84
10/15/2021260,400 shares $1.36 million +39.4%1.4%2.3 $5.23
9/30/2021186,800 shares $988,172.00 -51.6%1.0%1.8 $5.29
9/15/2021385,800 shares $1.85 million +2.0%2.0%2.2 $4.80
8/31/2021378,300 shares $1.94 million -7.8%2.0%1.8 $5.13
8/13/2021410,300 shares $2.32 million -22.3%2.1%1.8 $5.66
7/30/2021527,800 shares $3.03 million -10.6%2.7%2.3 $5.75
7/15/2021590,400 shares $3.50 million +61.7%2.9%2.6 $5.92
6/30/2021365,100 shares $2.37 million -68.3%1.8%1.6 $6.50
6/15/20211,150,000 shares $9.32 million +25.3%5.8%7.4 $8.10
5/28/2021917,800 shares $8.72 million -3.3%4.6%7.2 $9.50
5/14/2021949,300 shares $7.07 million +19.7%N/A8.3 $7.45
4/30/2021793,300 shares $6.73 million +16.7%N/A7.2 $8.48
4/15/2021679,700 shares $6.08 million +10.7%N/A6.1 $8.95
3/31/2021614,300 shares $5.20 million +12.6%N/A5.4 $8.47
3/15/2021545,700 shares $5.21 million +16.3%N/A5 $9.55
2/26/2021469,200 shares $4.49 million +9.8%N/A4.7 $9.57
2/12/2021427,200 shares $3.81 million +14.6%N/A4.3 $8.91
1/29/2021372,700 shares $2.78 million -0.9%N/A4.2 $7.45
1/15/2021376,200 shares $3.07 million +0.6%N/A4.4 $8.15
12/31/2020374,100 shares $2.53 million +8.7%N/A4.6 $6.75
12/15/2020344,200 shares $2.09 million -3.5%N/A4.3 $6.09
11/30/2020356,600 shares $2.42 million +8.7%N/A3.8 $6.80
10/30/2020312,700 shares $1.82 million -4.9%N/A3.5 $5.83
10/15/2020328,900 shares $2.22 million +6.9%N/A3.6 $6.76
9/30/2020307,600 shares $2.08 million +6.2%N/A3.1 $6.77
9/15/2020289,700 shares $2.05 million +12.1%N/A2.9 $7.06
8/31/2020258,400 shares $2.17 million -10.7%N/A2.6 $8.38
Do you think trading w/emotion helps? (Ad)

Holding onto our losers too long and cutting our winners at the first sign of profit. Steven recognized that the only way to really solve this problem was to build an automated trading bot using a machine that has zero emotion.

Click here to join Steven LIVE this week.
8/14/2020289,200 shares $2.56 million +9.3%N/A3.1 $8.85
7/31/2020264,600 shares $1.96 million -2.4%N/A2.8 $7.42
7/15/2020271,100 shares $2.20 million +38.3%N/A3.1 $8.12
6/30/2020196,100 shares $1.83 million +23.5%N/A2.4 $9.32
6/15/2020158,800 shares $1.39 million -17.2%N/A2.2 $8.76
5/29/2020191,800 shares $1.65 million -7.8%N/A2.5 $8.59
5/15/2020208,000 shares $1.84 million +3.9%N/A2.9 $8.86
4/30/2020200,200 shares $1.98 million -1.9%N/A3.1 $9.89
4/15/2020204,100 shares $1.94 million -2.7%N/A3 $9.49
3/31/2020209,800 shares $2.10 million -9.1%N/A2.7 $10.00
3/13/2020230,700 shares $2.30 million +1.6%N/A3.1 $9.98
2/28/2020227,000 shares $1.88 million +19.2%N/A2.7 $8.28
2/14/2020190,500 shares $1.72 million +9.6%N/A1.9 $9.04
1/31/2020173,900 shares $1.91 million -8.2%N/A1.8 $11.01
1/15/2020189,400 shares $1.86 million +14.7%N/A2.2 $9.80
12/31/2019165,200 shares $1.54 million -0.5%N/A2.1 $9.31
11/15/2019192,800 shares $2.15 million -11.7%1.8%6.2 $11.16
8/15/2019230,200 shares $2.97 million -2.6%15.5%6.4 $12.92

XFOR Short Interest - Frequently Asked Questions

What is X4 Pharmaceuticals' current short interest?

Short interest is the volume of X4 Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 11,880,000 shares of XFOR short. Learn More on X4 Pharmaceuticals' current short interest.

What is a good short interest ratio for X4 Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XFOR shares currently have a short interest ratio of 4.0. Learn More on X4 Pharmaceuticals's short interest ratio.

Is X4 Pharmaceuticals' short interest increasing or decreasing?

X4 Pharmaceuticals saw a decline in short interest in the month of May. As of May 31st, there was short interest totaling 11,880,000 shares, a decline of 2.7% from the previous total of 12,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does X4 Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to X4 Pharmaceuticals: Cidara Therapeutics, Inc. (2.45%), HilleVax, Inc. (8.06%), Exscientia plc (3.77%), ProKidney Corp. (22.95%), CARGO Therapeutics, Inc. (13.17%), REGENXBIO Inc. (8.77%), Taysha Gene Therapies, Inc. (8.62%), iTeos Therapeutics, Inc. (7.49%), Lexeo Therapeutics, Inc. (3.10%), Valneva SE (0.11%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks.

What does it mean to sell short X4 Pharmaceuticals stock?

Short selling XFOR is an investing strategy that aims to generate trading profit from X4 Pharmaceuticals as its price is falling. XFOR shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against X4 Pharmaceuticals?

A short squeeze for X4 Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XFOR, which in turn drives the price of the stock up even further.

How often is X4 Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XFOR, twice per month. The most recent reporting period available is May, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:XFOR) was last updated on 6/22/2024 by MarketBeat.com Staff

From Our Partners